Nombre del producto:cyclopent-1-ene-1-carboxylic acid

IUPAC Name:cyclopent-1-ene-1-carboxylic acid

CAS:1560-11-8
Fórmula molecular:C6H8O2
Pureza:98%
Número de catálogo:CM202326
Peso molecular:112.13

Unidad de embalaje Stock disponible Precio($) Cantidad
CM202326-10g in stock ǕƱȌ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1560-11-8
Fórmula molecular:C6H8O2
Punto de fusión:-
Código de sonrisas:O=C(C1=CCCC1)O
Densidad:
Número de catálogo:CM202326
Peso molecular:112.13
Punto de ebullición:210°C at 760 mmHg
Nº Mdl:MFCD00001396
Almacenamiento:Store at 2-8°C.

Category Infos

Cyclopentanes
Cyclopentane is a cycloalkane, an organic compound with a molecular formula of C5H10, a colorless and transparent liquid, insoluble in water, soluble in most organic solvents such as ethanol, ether, benzene, carbon tetrachloride, acetone, etc. It is mainly used as a solvent and chromatographic reference materials.
Cyclopentanes,where to buy Cyclopentanes
Cyclopentanes
Cyclopentane (also called C pentane) is a highly flammable alicyclic hydrocarbon with chemical formula C5H10 and CAS number 287-92-3, consisting of a ring of five carbon atoms each bonded with two hydrogen atoms above and below the plane. It occurs as a colorless liquid with a petrol-like odor.

Column Infos

Ribociclib
FDA has approved Novartis Kisqali(ribociclib) to reduce risk of recurrence in people with hormone receptor-positive/human epidermal growth factor receptor 2-negative(HR+/HER2-) early breast cancer (EBC).
Kisqali is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Targeting CDK4/6 with enhanced precision may play a role in ensuring that cancer cells do not continue to replicate uncontrollably. Beyond today’s FDA approval of Kisqali for EBC patients in the US, regulatory reviews for Kisqali as an EBC treatment are ongoing worldwide, including in the EU and China.

Related Products